Clearside Biomedical Correlations
CLSD Stock | USD 0.41 0.19 31.67% |
The current 90-days correlation between Clearside Biomedical and Kezar Life Sciences is 0.12 (i.e., Average diversification). The correlation of Clearside Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Clearside Biomedical Correlation With Market
Average diversification
The correlation between Clearside Biomedical and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Clearside Biomedical and DJI in the same portfolio, assuming nothing else is changed.
Clearside | Build AI portfolio with Clearside Stock |
Moving against Clearside Stock
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Clearside Stock performing well and Clearside Biomedical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Clearside Biomedical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CNTB | 4.77 | 1.78 | 0.33 | (3.41) | 3.62 | 13.24 | 39.41 | |||
CGEM | 2.58 | (0.17) | (0.04) | 0.00 | 3.47 | 4.81 | 16.72 | |||
EYPT | 3.65 | 0.87 | 0.21 | 0.87 | 3.42 | 10.34 | 25.16 | |||
KZR | 2.66 | (0.07) | (0.02) | 0.06 | 3.60 | 5.17 | 16.72 | |||
CDTX | 5.49 | 2.12 | 0.67 | 1.26 | 2.47 | 8.96 | 120.75 | |||
LPTX | 4.27 | 0.00 | 0.00 | 0.13 | 5.12 | 8.82 | 30.19 | |||
VTVT | 3.30 | (0.17) | 0.00 | (0.65) | 0.00 | 6.32 | 19.80 | |||
CRVS | 3.77 | 0.58 | 0.12 | 1.08 | 3.87 | 6.61 | 41.22 |
Clearside Biomedical Corporate Management
MD MBA | Chief AdvisorRetina | Profile | |
Jenny Kobin | Head Relations | Profile | |
FRCOphth FRCS | Chief Officer | Profile | |
Leslie Zacks | Chief Compliance Officer, General Counsel | Profile | |
Charles Deignan | Chief Officer | Profile | |
Susan Coultas | Chief Officer | Profile | |
Leslie JD | Secretary | Profile |